Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Observation of Pure Red Cell Aplasia in Chronic Kidney Disease Patients Using Hema-Plus at Ramathibodi Hospital
TCTR20170807003Phase 4Completed
- Sponsor
- Apexcela
- Start
- Jul 2017
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial in chronic kidney disease (CKD) and anemia of renal disease, sponsored by Apexcela. Primary endpoint: Incidence of pure red cell aplasia. Started Jul 2017; status: completed.
02
Conditions
chronic kidney disease (CKD)anemia of renal disease
Beyond the preview
Go deeper on TCTR20170807003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170807003.